Joint Stock Company Kaspi.kz
Joint Stock Company Kaspi.kz (KSPI) Financial Performance & Income Statement Overview
Analyze Joint Stock Company Kaspi.kz (KSPI) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Joint Stock Company Kaspi.kz (KSPI) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Joint Stock Company Kaspi.kz KSPI financial performance.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $816.05B | $724.46B | $652.59B | $592.85B |
Cost of Revenue | $391.83B | $264.38B | $243.40B | $79.70B |
Gross Profit | $424.22B | $460.08B | $409.20B | $513.15B |
Gross Profit Ratio | $0.52 | $0.64 | $0.63 | $0.87 |
R&D Expenses | $42.90B | $29.34B | $27.54B | $26.24B |
SG&A Expenses | $39.18B | $23.37B | $17.94B | $18.25B |
Operating Expenses | $122.57B | $82.38B | $73.05B | $76.17B |
Total Costs & Expenses | $514.40B | $346.76B | $316.44B | $155.87B |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $0.00 | $0.00 | $0.00 | $147.09B |
Depreciation & Amortization | $0.00 | $0.00 | $0.00 | -$694.00M |
EBITDA | $301.65B | $377.70B | $336.15B | $443.37B |
EBITDA Ratio | $0.37 | $0.52 | $0.52 | $0.75 |
Operating Income | $301.65B | $377.70B | $336.15B | $450.45B |
Operating Income Ratio | $0.37 | $0.52 | $0.52 | $0.76 |
Other Income/Expenses (Net) | $5.80B | $5.89B | -$2.84B | -$140.70B |
Income Before Tax | $307.45B | $383.59B | $333.31B | $296.29B |
Income Before Tax Ratio | $0.38 | $0.53 | $0.51 | $0.50 |
Income Tax Expense | $53.40B | $67.19B | $58.94B | $53.67B |
Net Income | $254.05B | $311.90B | $269.69B | $238.55B |
Net Income Ratio | $0.31 | $0.43 | $0.41 | $0.40 |
EPS | $1336.99 | $1642.17 | $1419.00 | $1277.41 |
Diluted EPS | $1336.99 | $1629.10 | $1409.00 | $1267.24 |
Weighted Avg Shares Outstanding | $190.02M | $189.93M | $190.06M | $189.93M |
Weighted Avg Shares Outstanding (Diluted) | $190.02M | $191.45M | $191.41M | $191.45M |
Financial performance has remained strong, with revenue growing from $592.85B in Q2 2024 to $816.05B in Q1 2025. Gross profit continued to perform well, with margins at 52% in the latest quarter. Operating income reached $301.65B in Q1 2025, holding a steady 37% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $301.65B. Net income dropped to $254.05B, keeping EPS at $1336.99. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan